CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $342,898,837
- in 74 filings, $342.1M under 10b5-1 plans
Net −$342,898,837. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-02 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −896 | $563.86 | $505K | 22,782 |
| 2026-04-02 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −2,201 | $564.82 | $1.2M | 20,581 |
| 2026-04-02 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −742 | $565.99 | $420K | 19,839 |
| 2026-04-02 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −323 | $566.82 | $183K | 19,516 |
| 2026-04-02 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −400 | $567.95 | $227K | 19,116 |
| 2026-04-02 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −120 | $569.75 | $68K | 18,996 |
| 2026-04-02 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −120 | $571.65 | $69K | 18,876 |
| 2026-04-02 | EDGEMOND JAMES CFO AND TREASURER | Option exercise · Stock Option 10b5-1 | −10,000 | 122,500 | ||
| 2026-04-02 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $146.03 | $1.4M | 50,013 |
| 2026-04-02 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −65 | $552.25 | $36K | 49,948 |
| 2026-04-02 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −175 | $553.50 | $97K | 49,773 |
| 2026-04-02 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −394 | $554.45 | $218K | 49,379 |
| 2026-04-02 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,058 | $555.41 | $588K | 48,321 |
| 2026-04-02 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −808 | $556.52 | $450K | 47,513 |
| 2026-04-02 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −780 | $557.40 | $435K | 46,733 |
| 2026-04-02 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −440 | $558.51 | $246K | 46,293 |
| 2026-04-02 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −40 | $559.98 | $22K | 46,253 |
| 2026-04-02 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −570 | $561.60 | $320K | 45,683 |
| 2026-04-02 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −378 | $562.49 | $213K | 45,305 |
| 2026-04-02 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −865 | $563.52 | $487K | 44,440 |
Page 131 of 171 · 3,408 trades